Literature DB >> 3807271

Serum laminin--its concentration increases with portal hypertension in cirrhotic liver disease.

A M Gressner, W Tittor.   

Abstract

The concentrations in serum of the high molecular weight glycoprotein laminin and of the N-terminal propeptide of type III procollagen were determined in various histologically proven fibrotic liver diseases (n = 33), of which the portal venous pressure has been measured indirectly. The concentrations of both biomatrix proteins were related to the portal venous pressure. Laminin in serum of normal persons (n = 146) ranged from 0.81 to 1.43 U/ml. Compared with the mean normal concentration (1.04 U/ml) the glycoprotein is increased in fibrotic liver lesions in parallel with the severity of the fibrotic organ transformation reaching the highest values (2.58 +/- 0.87 U/ml, P less than 0.001) in liver cirrhosis (n = 12). The level of N-terminal propeptide of type III procollagen increased similarly, but the concentrations of both matrix proteins exhibit only weak statistical correlations (r = 0.6680). The level of laminin is correlated strongly with the elevation of the portal venous pressure in cirrhotic (r = 0.9206) and fibrotic (r = 0.7157) subjects. For the propeptide of procollagen the respective correlation is r = 0.4808. Molecular sieve chromatography reveals a heterogeneous composition of laminin-related antigens in serum with two main molecular weight fractions of 700 and 300 kD, respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3807271     DOI: 10.1007/bf01734467

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  52 in total

1.  Properties of a basement membrane-related glycoprotein synthesized in culture by a mouse embryonal carcinoma-derived cell line.

Authors:  A E Chung; R Jaffe; I L Freeman; J P Vergnes; J E Braginski; B Carlin
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

2.  Immunochemical properties of the aminopropeptide of procollagen type III.

Authors:  H Rohde; P Bruckner; R Timpl
Journal:  Eur J Biochem       Date:  1983-09-15

3.  Nature of the collagenous protein in a tumor basement membrane.

Authors:  R Timpl; G R Martin; P Bruckner; G Wick; H Wiedemann
Journal:  Eur J Biochem       Date:  1978-03

4.  Serum concentration of procollagen-III-peptide in comparison with the serum activity of N-acetyl-beta-glucosaminidase for diagnosis of the activity of liver fibrosis in patients with chronic active liver diseases.

Authors:  W Ackermann; G Pott; B Voss; K M Müller; U Gerlach
Journal:  Clin Chim Acta       Date:  1981-05       Impact factor: 3.786

5.  Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum.

Authors:  O Niemelä; L Risteli; E A Sotaniemi; J Risteli
Journal:  Clin Chim Acta       Date:  1982-09-01       Impact factor: 3.786

6.  Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat.

Authors:  H Orrego; L M Blendis; I R Crossley; A Medline; A Macdonald; S Ritchie; Y Israel
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

7.  Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin.

Authors:  E Hahn; G Wick; D Pencev; R Timpl
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

8.  Contractile fibroblasts in chronic alcoholic cirrhosis.

Authors:  R Rudolph; W J McClure; M Woodward
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

9.  The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease.

Authors:  A Frei; A Zimmermann; K Weigand
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

10.  Entactin, a novel basal lamina-associated sulfated glycoprotein.

Authors:  B Carlin; R Jaffe; B Bender; A E Chung
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

View more
  5 in total

1.  Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome.

Authors:  B Stoiser; F Thalhammer; I El-Menyawi; A Wilfing; F Daxböck; G J Locker; H Burgmann
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

Review 2.  Hepatic fibrosis--current concepts of pathogenesis and therapy.

Authors:  B Högemann; W Domschke
Journal:  Gastroenterol Jpn       Date:  1993-08

3.  Serum concentrations of laminin in cirrhosis of the liver.

Authors:  J Collazos; F Díaz; J Genollá
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

Review 4.  Is there a place for serum laminin determination in patients with liver disease and cancer?

Authors:  Heitor Rosa; Edison Roberto Parise
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

5.  Correlation between serum laminin levels and prognosis of acute myocardial infarction.

Authors:  Lou-Yuan Xu; Ling Xie; Jing Wang; Hai-Xiao Chen; Hong-Li Cai; Li-Jun Tian; Qing Zhang
Journal:  Front Cardiovasc Med       Date:  2022-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.